Skip to main content
. 2021 Feb 23;21(4):323. doi: 10.3892/ol.2021.12585

Figure 6.

Figure 6.

Potential co-expressed genes of NCAPG in breast cancer. Expression levels of (A) CCNA2, (B) CCNB1, (C) CCNB2, (D) CCNE2, (E) CDC25C, (F) CDK1, (G) CDK2, (H) CHEK1, (I) CHEK2, (J) GTSE1, (K) RRM2 and (L) SKP2 in breast cancer analyzed using UALCAN. Prognostic roles of (M) CCNA2, (N) CCNB1, (O) CCNB2, (P) CCNE2, (Q) CDC25C, (R) CDK1, (S) CDK2, (T) CHEK1, (U) CHEK2, (V) GTSE1, (W) RRM2 and (X) SKP2 in breast cancer analyzed using Kaplan-Meier Plotter. NCAPG, non-SMC condensin I complex subunit G; BC, breast cancer; CCN, cyclin; CDC25C, cell division cyclin 25 homolog C; CHEK, checkpoint kinase; GTSE1, G2 and S phase expressed 1; RRM2, ribonucleotide reductase regulatory subunit M2; SKP2, S-phase kinase-associated protein 2; TCGA, The Cancer Genome Atlas.